WEDNESDAY, Sept. 20, 2017 -- Although about 1 in 7 men will be eventually be diagnosed with prostate cancer in his lifetime, the warning signs of the disease are often vague and may be confused with other conditions, experts at Fox Chase Cancer Center say.
Prostate cancer can be serious but it's often not fatal. Men should talk to their doctor about the risks and benefits of getting screened for the disease, advised Dr. Alexander Kutikov, chief of the division of urologic oncology at Fox Chase in Philadelphia.
TUESDAY, Sept. 5, 2017 -- Despite ongoing debate over the value of prostate cancer screening, a new review says it can indeed reduce a man's risk of dying from the disease.
Early tumor detection using the prostate-specific antigen (PSA) blood test lowers a man's risk of prostate cancer death by 25 percent to 32 percent, the new analysis of two major trials of PSA testing found.
THURSDAY, June 29, 2017 -- Popular hormone-based drugs for treating an enlarged prostate could increase men's risk of type 2 diabetes, heart disease or stroke, a new study suggests.
A group of German men taking the drug Avodart (dutasteride) for three years wound up with higher blood sugar and cholesterol levels than men taking another class of prostate medication that does not affect male hormones, the researchers reported.